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ABSTRACT OF THESIS

USE OF HYBRID DIFFUSE OPTICAL SPECTROSCOPIES IN CONTINUOUS
MONITORING OF BLOOD FLOW, BLOOD OXYGENATION, AND OXYGEN
CONSUMPTION RATE IN EXERCISING SKELETAL MUSCLE
This study combines noninvasive hybrid diffuse optical spectroscopies [near-infrared
spectroscopy (NIRS) and diffuse correlation spectroscopy (DCS)] with occlusive
calibration for continuous measurement of absolute blood flow (BF), tissue blood
oxygenation (StO2), and
2) in exercising skeletal muscle.
Subjects performed rhythmic dynamic handgrip exercise, while an optical probe
connected to a hybrid NIRS/DCS flow-oximeter directly monitored oxy-, deoxy-, and
total hemoglobin concentrations ([HbO2], [Hb], and [tHb]), StO2, relative BF (rBF), and
O2
2
2 were
obtained through venous and arterial occlusions, respectively, and used to calibrate
continuous relative parameters. Previously known problems with muscle fiber motion
artifact in optical measurements were mitigated with a novel dynamometer-based gating
algorithm. Nine healthy young subjects were measured and results validated against
previous literature findings. Ten older subjects with fibromyalgia and thirteen agematched healthy controls were then successfully measured to observe differences in
hemodynamic and metabolic response to exercise. This study demonstrates a novel
application of NIRS/DCS technology to simultaneously evaluate quantitative
hemodynamic and metabolic parameters in exercising skeletal muscle. This method has
broad application to research and clinical assessment of disease (e.g. peripheral vascular
disease, fibromyalgia), treatment evaluation, and sports medicine.
KEYWORDS: Diffuse correlation spectroscopy; near-infrared spectroscopy; blood flow;
blood oxygenation; oxygen consumption rate
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CHAPTER 1: INTRODUCTION

1.1 Blood Flow and Metabolism in Health and Disease
To produce energy for normal cellular function, living cells consume oxygen and
produce metabolic waste via aerobic respiration. Nutrients are supplied and waste is
removed via diffusion through capillary membranes in the microvasculature of the
cardiovascular system, which is regulated by many factors, both centrally (central
nervous system) and locally (mechano-chemical response).

The balance of oxygen

delivery and oxygen consumption is critical in maintaining homeostasis for health. In
order to fully understand how certain tissues function, and the regulatory mechanisms
that maintain their homeostatic environment, it is essential to monitor both the nutrient
supply and consumption at a local level. As such, blood flow (BF), oxygen consumption
rate (

2),

and tissue blood oxygen saturation (StO2) can all provide useful metrics for

evaluating tissue health and disease.
Skeletal muscle provides an excellent platform for studying cardiovascular and
metabolic regulation, as it comprises approximately 40% of total body mass, and under
working conditions, can utilize up to 85% of total cardiac output [1]. Characterization of
circulatory and metabolic function in skeletal muscle has provided key insight into the
pathophysiology, diagnosis, and treatment of common and widespread diseases affecting
millions of people annually (e.g., 12–14 % of older adults in U.S. with peripheral arterial
disease [2-4], 10 million with fibromyalgia [5, 6], and 5 million with chronic heart failure
[7-9]), causing increased health cost and impaired quality of life.

1

In addition to numerous applications to exercise physiology and sports medicine [10],
quantification of hemodynamic/metabolic parameters has potential to characterize disease
status by monitoring abnormalities. Because functional impairments are not always
apparent at rest, it is important to study hemodynamic and metabolic changes in response
to stimulus [3, 8, 11-13]. For example, patients with peripheral arterial disease can
exhibit normal resting blood pressures and flow, but impaired flow in following an
exercise stress test [14]. Rhythmic exercise is an effective method for inducing changes
in both BF and

2.

The ability to simultaneously monitor these parameters

continuously and noninvasively during exercise has great potential for investigating
muscle and exercise physiology, improving diagnosis and treatment assessment, as well
as understanding pathophysiology of disease affecting skeletal muscle.

1.2 Blood Flow Measurement
There have been several previous efforts to monitor flow non-invasively, including
Doppler ultrasound, laser Doppler, positron emission tomography (PET), and arterialspin-labeled MRI (ASL-MRI) [15]. Doppler ultrasound is widely used, but is limited to
imaging large vessels [16]. Flow through these vessels represents regional flow, which
can obscure details found in evaluation of individual muscles [17, 18]. Laser Doppler is
capable of monitoring flow in the small vessels of the microvasculature, but is incapable
of penetrating to deep tissues, restricting measurement to shallow tissue (i.e. skin flow)
[19]. PET [20] and ASL-MRI [21] are both capable of measuring flow in deep tissues,
but require expensive and cumbersome equipment which can restrict the range of motion
for exercise studies, and is often not practical for some laboratories or clinics.

2

In

addition, most of these technologies are sensitive to muscle motion artifact, which can
distort signals from contracting muscle. The limitations of these technologies have
prevented widespread use in exercise research and clinical settings. The need exists,
therefore, for a noninvasive technology capable of monitoring local deep tissue blood
flow without the restriction imposed by large expensive equipment.

1.3 Blood Oxygenation Measurement
There are many different techniques for measuring blood oxygenation in vivo,
including blood sampling for arterial blood gas tests (ABGs) [22], functional MRI
(fMRI) [23], oxygen electrodes [24], spectroscopic techniques such as electron
paramagnetic resonance (EPR), nuclear magnetic resonance (NMR) [25], and nearinfrared spectroscopy (NIRS) tissue-oximetry [26].

Concentration of metabolites in

blood that depend on the presence of oxygen can also be used to monitor oxygen levels,
but is an indirect secondary measurement which is also invasive [25].

ABGs are

invasive, and are generally reflective only of arterial blood oxygenation, not local tissue
blood oxygenation or oxygen uptake. Oxygen electrodes are invasive and can only
measure oxygen partial pressure (PO2) in a tiny spot, and often produce inconsistent
results in highly heterogeneous tissues. fMRI, EPR, and NMR are very expensive and
cumbersome, and not frequently used in many clinical or research environments. By far
the most popular method for measuring blood oxygenation is NIRS tissue-oximetry.
NIRS allows for noninvasive measurement in vivo, and advances in technology have
made NIRS monitors inexpensive, fast, portable, and easy to use.

3

1.4

2)

Measurement

Oxygen consumption in skeletal muscle has also been quantified by a variety of
technologies. Spirometry measures whole body

2,

but does not provide information

regarding the contributions of individual organs or tissues [27]. Muscle

2

can be

determined invasively using catheterization and blood sampling, with application of the
Fick principle [28, 29].

Blood sampling is well-established, but aside from the

invasiveness of the procedure, the data provided remain regional in scope of O2
dynamics.

Samples are usually taken from major vessels which perfuse groups of

muscles, and do not assess dynamics at the level of the local microvasculature. 31phosphorus magnetic resonance spectroscopy (31P-MRS) is capable of monitoring local
muscle oxygen kinetics, but requires expensive and cumbersome equipment which limits
measurement during exercise, has limited sensitivity, and poor temporal resolution [30].
Thus, there is a need for a simple method to determine local muscle

2

easily and

noninvasively in exercising muscle.

1.5 Near-infrared Spectroscopy (NIRS)
Near-infrared (NIR) diffuse spectroscopic technologies for tissue hemodynamic
monitoring have gained popularity in recent years, including many studies investigating
muscle physiology [10, 31, 32]. NIR technology offers several attractive features making
it ideal for research and clinical use, including noninvasiveness, portability, and
inexpensiveness. NIR light is well-suited to biomedical applications due to the low
absorption of tissue in the spectral (600 – 950 nm) window (see Figure 1) in biological
tissues [33]. Reduced absorption allows for deep penetration of photons into the tissue of

4

interest.

As they pass through the tissue, photons interact with scatterers (cell

membranes, organelles, nuclei) and absorbers (deoxy- and oxy-hemoglobin, water). In a
scattering event, light is redirected along a new path, and in an absorbing event, light
intensity is attenuated. At wavelengths in the NIR range, scattering is much greater than
absorption, and photons undergo diffusive motion as they are reflected back to the
surface of the tissue.

Tissue optical properties are characterized by absorption and

reduced scattering coefficients, represented by µa and µs’

-1

units), respectively.

NIRS is typically categorized into three different techniques based on illumination
type [34].

The continuous-wave (CW) paradigm uses constant illumination, and

measures light attenuation through the tissue (see Figure 2a). The frequency domain
(FD) paradigm uses intensity modulated light to illuminate the tissue, and measures both
the attenuation and the phase shift at the detector (see Figure 2b). The time-domain (TD)
paradigm is based on a pulse injection of light into the tissue, and the time-resolved
measurement at the detector (see Figure 2c). The shape of the detected pulse following
attenuation and broadening provides property information about the propagation tissue.
Of the techniques, CW is the simplest and least expensive, but only provides relative
values for deoxy-, oxy-, and total hemoglobin concentrations ([Hb], [HbO2], and [tHb]).
FD and TD techniques are capable of measuring absolute µa and µs’
concentrations, but are also more expensive and technologically complex. In addition,
the TD technique provides more spatial information about properties at differing depths,
but at a cost to temporal resolution.

5

Figure 1. Absorption Spectra of Hemoglobin and Water
The absorption coefficients (µa

w

w

λ

2),

deoxygenated hemoglobin (Hb), and water (H2O). Within the NIR spectral window (~600 – 900 nm), light
is able to penetrate deep tissue due to low absorption.

Figure 2. NIRS Modalities
Sample input and output intensity signals representing the three types of NIRS techniques. Panel (a) shows
continuous wave (CW) spectroscopy, in which attenuated intensity of continuous illumination is monitored.
Panel (b) shows frequency domain (FD) spectroscopy, in which input light is modulated and the amplitude
attenuation and phase shifts are detected. Panel (c) shows time domain (TD) spectroscopy, in which an
impulse of light is emitted into the tissue, and the intensity change with respect to time is detected. In the
figure, I represent intensity Φ

the frequency of modulation.
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1.6 Diffuse Correlation Spectroscopy (DCS)
Diffuse correlation spectroscopy (DCS) is a relatively new technique for monitoring
relative blood flow changes in deep tissues [33, 35, 36]. DCS takes advantage of the
same optical window as traditional NIRS techniques, but employs a long-coherence NIR
CW laser as the light source, and monitors speckle fluctuations at the tissue surface using
photodetectors. Speckle fluctuations are caused by photon interactions with moving
scatterers, primarily red blood cells (RBCs) in the microvasculature. Each scattering
event causes a random scattering phase shift in the light field of the photons, and the
superposition of multiple fields with different phases creates an interference pattern. The
time-dependent light intensity fluctuations can be quantified by temporal autocorrelation
functions.
DCS relative flow measurements are obtained by fitting experimentally obtained
normalized temporal intensity autocorrelation functions from the speckle fluctuation to
theoretical solutions based on the correlation diffusion equation, from which a blood flow
index (BFI) is derived. Relative change in blood flow (rBF) can then be calculated by
normalizing BFI to its baseline value (e.g. before physiological changes). DCS
technology has many advantages, including noninvasiveness, portability, high temporal
resolution, deep tissue penetration, and low running cost. All of these features make
DCS an attractive option for clinical studies on even fragile patient populations, as well
as research studies in the field.
DCS for rBF measurement has been applied to a wide variety of tissues, including
human brain [37-42], head/neck tumor [43, 44], breast [45, 46], and muscle [47-49], and
has been validated by a variety of local flow measurement techniques, including laser

7

Doppler [33, 50], Xenon-CT [39], and perfusion MRI (ASL-MRI) [33, 49]. In moving
skeletal muscle, fiber motion during contraction can also cause scattering and introduce a
motion artifact leading to overestimation of flow. This poses a significant problem for
monitoring hemodynamics during physical activity [51].

Previous efforts to reduce

motion artifact have required precise co-registration of signals with a dynamometer and
off-line analysis [50].

1.7 Diffuse Optical Measurement Limitation and Current Study
It is apparent from review of literature, that there is a need for a simple method to
noninvasively quantify local blood flow, blood oxygen saturation, and oxygen
consumption in muscle during exercise without overly restricting movement.

NIRS

technology is capable of monitoring absolute oxygenation in tissue, and DCS technology
is capable of directly monitoring relative blood flow (rBF) in muscle. Combining these
two technologies, it is possible to derive relative oxygen consumption (r

2)

based on

the Fick principle [13] (see Section 2.4). With such combination of multiple parameters,
investigators and clinicians could be capable of obtaining a much clearer picture of
muscle hemodynamics and metabolism.
Currently DCS-based measurements are limited to providing only relative
information, as the flow index is calculated relative to the baseline. To overcome this
limitation, it is necessary to employ some method of calibration. Absolute measurements
of flow can be obtained readily with NIRS through venous occlusion protocols [1, 28, 5254]. This technique has been validated against other modalities including the clinically
accepted method of strain-gauge plethysmography.

8

Although this method provides

absolute BF measurement, it requires interruption of natural flow response (as occlusions
require ~10 s), which is not ideal for monitoring the rapid hemodynamic changes
associated with exercise and recovery. Employing this protocol at rest determines an
absolute baseline flow which can be used to calibrate the continuous relative DCS
measurements. This eliminates the need for additional occlusions during exercise and
allows for direct measurement of the natural flow response with higher temporal
resolution. Similarly, the derived r
[28, 55, 56]. Absolute

2

2

signal can be calibrated through arterial occlusion

measurement can be determined by monitoring the rate at

which muscle converts oxy-hemoglobin (HbO2) to deoxy-hemoglobin (Hb) while blood
supply and return is occluded. The resting baseline absolute
exercise can then be used to calibrate the r

2

2

determined prior to

signal from the hybrid instrument.

Muscle motion artifact presents another limitation preventing widespread application
of DCS-based measurement techniques to exercise study. In order to overcome this
limitation, it is necessary to employ a method which eliminates measurement while the
muscle is contracting. To address this issue, a dynamometer based gating algorithm was
embedded into the control software of a hybrid instrument (see Chapter 2.3). This
algorithm uses signals generated by a dynamometer to determine the contraction status of
muscle, and control data acquisition accordingly.
This study combines occlusive calibration protocols with gated NIRS/DCS
measurements to investigate the feasibility of directly measuring absolute BF, StO2, and
2

in actively exercising skeletal muscle. This method was applied to dynamic exercise

in the forearm flexor muscles of a nine young healthy subjects. Following validation of
results in the young healthy population, the technique was applied to eleven fibromyalgia

9

patients and thirteen age-matched healthy controls to investigate differences in
hemodynamic and metabolic responses to exercise.
This thesis is organized into the following chapters. Chapter 2 discusses the theory
behind NIRS and DCS measurements, and describes the hybrid instrument and its data
acquisition sequence. Chapter 3 describes the measurement protocol, beginning with an
overview of procedure, followed by a more detailed description of each individual
component. The details of the gating algorithm are also described. Chapter 4 describes
the experimental procedures for the validation study in young healthy subjects. Chapter 5
details the application of the method to a fibromyalgia disease population (with agematched healthy controls). Results are presented with accompanying discussion and
critique in Chapter 6. Finally, Chapter 7 discusses the novel contributions of this work as
well as directions for future research.
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CHAPTER 2: THEORY

Measurements in this study were made using a hybrid NIR diffuse optical instrument
which combined a commercial FD NIR tissue-oximeter (the Imagent from ISS, Inc., IL,
USA) [57], and a custom-built NIR DCS flow-oximeter [58] (see Figure 3). These two
devices communicate through control software in external computers to make concurrent
measurements of tissue optical properties and blood flow indices, from which
hemodynamic and metabolic parameters can be derived. Parameters were evaluated in a
young healthy population, as well as a fibromyalgia patient population with age-matched
healthy controls. This chapter is organized as follows. First, the theory behind FD NIRS
measurement of tissue optical properties and chromophore concentration calculation is
discussed in Chapter 2.1. Then the principles behind DCS measurement of blood flow
indices are outlined in Chapter 2.2.

The configuration of the hybrid instrument is

described in Chapter 2.3.

2

Chapter 2.4.
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measurement is described in

Figure 3. Hybrid Optical Instrument
The hybrid optical instrument combining a commercial Imagent (ISS, Inc.) FD spatially-resolved NIRS
oximeter and the custom-built DCS instrument. The Imagent instrument includes 110 MHz modulated
sources (of which the 690 and 830 nm wavelengths are used), photomultiplier tube (PMT), and desktop
computer control, which ultimately calculates tissue optical properties (µa and µs’

deoxy-, oxy-, and

total hemoglobin concentrations ([Hb], [HbO2], and [tHb]). NIRS measures the modulated light amplitude
(ac), average light intensity (dc), and phase φ

The DCS instrumentation includes

an 830 nm laser source, avalanche photodiodes (APDs), autocorrelator board, and laptop computer control,
which ultimately calculates the blood flow index (BFI). The two alternate measurements via triggers.
Light is delivered through optical fibers to a black probe placed on the skin surface (see Figure 4).

2.1 NIRS for Oxygenation Measurement
A commercial 4-wavelength (690, 750, 780, and 830 nm) FD multi-distance spatially
resolved spectroscopy instrument (Imagent, ISS) is employed to quantify µa, µs’, [HbO2],
and [Hb] in muscle. Total hemoglobin concentration ([tHb]) is calculated as: [tHb] =
[HbO2] + [Hb], and tissue blood oxygen saturation (StO2) is calculated as: StO2 = 100% ·
12

[HbO2]/[tHb]. Parameters are measured using only the 690 and 830 nm wavelengths,
modulated at 110 MHz. NIR light is delivered to the tissue via optical source fibers, and
backscattered photons are collected by detector fibers located a few centimeters away.
Source and detector fibers are embedded in a black flexible probe placed on the skin
surface. Four source fibers per wavelength (8 total) are placed at distances of 2.0, 2.5,
3.0, and 3.5 cm from a detector fiber bundle (see Figure 4). The detector fibers are
connected to a photomultiplier tube (PMT), which converts the light intensity to a voltage
signal. From the detected light, changes in modulated light amplitude (ac), average light
intensity (dc), and phase shift φ

source-detector separation

(r). Through solutions to a photon diffusion equation [57], µa and µs’
from the detected

φ

For a semi-infinite

geometry, it has been found that an approximate linear relationship exists between r and
the logarithmic ac·r2, logarithmic dc·r2

φ.

These approximate relationships are

described by the following equations [59] and adopted in the ISS Imagent instrument:









ln dc  r 2  rSdc μ a , μ s  In dc D, K dc 
'

μ 
where Sdc   a 
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(4)

(5)

μ 
where Sac   a 
D
w

ω

q

1/ 2


1   ω
  vμ a






2






1/ 2


 1



1/ 2

(6)

v is the speed of light in the medium, D
D ≈ 1/3µs’ Kφ is the relative phase of the source plus

any phase shifts outside the sample, Kac and Kdc are constants depending on detector
sensitivity factors, modulation depth, and source intensity, and Indc, Inφ, and Inac are line
intercepts from the multiple separation line fit. Only

φ

r2·ac or

r2·dc slope are necessary to obtain optical properties for each wavelength.

The

combination of Sac and Sφ has the added advantage of reducing influence from
background light [60]. The absorption coefficient can be decomposed into contributions
from individual tissue chromophores by the following [33]:
μ a (λ)   ε i (λ)[i]

(7)

i

w

εi λ

-dependent extinction coefficient for the ith chromophore,

w

and [i] is the concentration for the ith chromophore, to be reconstructed.
During preliminary testing, data showed that the phase component of FD spatially
resolved spectroscopy introduced too much noise for adequate slope fitting during BF
calibration (see Section 3.2). Thus, only the amplitude differences from a single sourcedetector separation (2.0 cm) were used to calculate relative changes in chromophore
Δ[

2]

Δ[

]

-Lambert law [61], and added to

absolute baselines (determined as the average of the first 10 data points).
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Figure 4. Hybrid Optical Probe
The configuration for the hybrid optical probe, embedded with source and detector fibers for both the
Imagent NIRS and the DCS instruments. Probe is of black flexible silicon, and the surface shown is placed
in direct contact with the skin surface.

2.2 DCS for Blood Flow Measurement
Diffuse correlation spectroscopy (DCS), also known as diffusing wave spectroscopy
(DWS) [62], is an extension of the single scattering dynamic light scattering (DLS)
technique to the multiple scattering limit [40].

In optically thick systems, such as

biological tissue, light is scattered multiple times before being absorbed or leaving the
sample. By accounting for multiple scattering events, DCS is able to probe and obtain
information from deep tissues. Details regarding the complete theoretical development of
DCS can be found elsewhere [63].
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DCS uses a single CW laser (830 nm) with long coherence length (> 5 meter) to emit
photons into the tissue through a multimode optical fiber embedded in the same black
flexible probe as the FD NIRS fibers (see Figure 4). Four single-mode detector fibers at
a specified distance away measure light speckle fluctuations at the surface caused by
moving scatterers (primarily red blood cells). The photons are detected and counted by
avalanche photodiodes (APDs, PerkinElmer Inc., Canada), and its output is fed to an
autocorrelator board (correlator.com, NJ). The autocorrelator determines the normalized
light intensity temporal autocorrelation function, g2(r,τ) [40]:

g 2 (r, ) 

I (t ) I (t   )
I (t )

(8)

2

where I(t) is the intensity at time t, the angular brackets denote temporal average, r is the
general vector from the source to a point of detection, and τ is the delay time.

The

g2(r,τ) functions from the four detectors are averaged together to improve the signal-tonoise ratio (SNR). The normalized intensity temporal autocorrelation function is then
related to the normalized electric field autocorrelation function (g1(r τ

via the Siegert

relationship [64]:

g 2 r,   1   g1 r, 

2

(9)

where β depends on laser stability, coherence length, and detection optics, and is
inversely proportional to the number of speckles detected.
experimentally for each measurement from the intercept of g2(r τ

β is determined
τ→0

Light diffusion in highly scattering media is characterized by the correlation diffusion
equation, which is rigorously derived elsewhere [35, 40, 63]:
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'
2
 D 2  v  a   s k 0  r 2 ( )   G1 (r, )  vS0 (r)
3




(10)

where D ≈ v/(3µs’) is the photon diffusion coefficient, v is the speed of light in the
medium, k0 = 2π /λ

w

vector of photons in the medium, and S0(r) is the source-

light distribution. The term <Δr2 τ >
τ

-square displacement of scatterers in

effective “

"

unnormalized electric field autocorrelation function.

q

G1(r τ

The normalized electric field

autocorrelation function is determined as g1(r τ = G1(r τ /G1(r,0). The homogenous CW
solution to Eq. 10 for a semi-infinite geometry is:

G1 (  , ) 

vS0  e  K ( ) r1 e  K ( ) r2


4D  r1
r2





(11)

where ρ is the source-detector separation distance, S0 is the source intensity,
'
'2
2
K 2 ( )  3μ a μ s  μ s k0   r 2 ( )  , r1  [  2  ( z  z0 ) 2 ] 2 , r2  [  2  ( z  z0  2 zb ) 2 ] 2 ,
1

1

'

'
z 0  1 / μ s , zb  2(1  Reff ) / 3μ s (1  Reff ) , Reff  1.440n 2  0.710n 1  0.668  0.0636n .

Reff accounts for the mismatch of refractive indices between air and the medium, with n as
the ratio between them.

For biological tissue, n ≈ 1 33 [33].
0 0 0

tissue surface being in the z = 0 plane (see Figure 5).
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For a semi-infinite
ρ 0 0 w

Figure 5. Tissue Absorption and Scattering
The source and detector placement on the tissue surface. Solid circles with gray arrows represent moving
scatterers (RBCs). Black and light gray lines indicate potential photon paths.

The movement of dynamic scatterers in biological tissue is characterized by Brownian
motion, <Δr2 τ > = 6DBτ w

DB is the effective Brownian diffusion coefficient. The
α

w

αDB represents a blood flow index (BFI), which is used to
determine relative blood flow (rBF) by comparison with the baseline resting BFI:
rBF 

BFI
BFIbaseline

To quantify the BFI, first g2 ρ τ

(12)
~26

autocorrelator board. This measurement is repeated multiple times within a given period
(300 ms), and the g2 ρ τ

to achieve sufficient signal-to-noise

ratio. The measured intensity autocorrelation curve is then transformed to the electric
field autocorrelation curve, g1 ρ τ

S

Eq. 9). The experimental

g1 ρ τ is then fit with the theoretical solution of the correlation diffusion equation (Eq.
10 and Eq. 11)

αDB and using a least mean squares approach. The overall

process of DCS measurement is shown in Figure 6.
18

Figure 6. DCS Measurement and Analysis
A step-by-step guide to DCS measurement and analysis. First, the laser illuminates the tissue, and photon
speckle fluctuations are captured with the APDs. The data are sent to an autocorrelator board, which
calculates the temporal intensity autocorrelation function, g2 τ
temporal electric field autocorrelation function, g1 τ
w

S

T

z
T

1

τ

αDB, which is also the blood flow index (BFI). From the

BFI, rBF can be determined by normalizing to the baseline.
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2.3 The Hybrid Instrument
The Imagent NIRS instrument and the DCS instrument were combined into a single
hybrid device known as a hybrid tissue flow-oximeter (see Figure 3). This device has
been described in detail elsewhere [58], and is capable of collecting data from either
device individually or collectively by alternating sequentially between the two. When
operating in tandem, a single acquisition sequence first begins with activation of the DCS
laser, followed by data collection from the autocorrelator.

The acquired data with

individual autocorrelation functions is stored in a .dat file for later offline data analysis.
The DCS laser is then deactivated, and notification is sent to the Imagent via a TTL
trigger to begin NIRS data acquisition. NIRS acquisition begins with activation of a
single 830 nm laser (4 in total) at a given source-detector separation (2.0, 2.5, 3.0 or 3.5
cm), followed by data collection from the PMT.

Data collection iterates through

sequential activation of each 830 nm laser (for a given source-detector separation). After
data collection, the 830 laser is deactivated, and the sequence repeats for the 690 nm
lasers. When a single round of data collection is completed for each laser at each
separation, ac, dc, and phase data are stored in a .txt file. This .txt file can then later be
analyzed by supplemental processing to calculate parameters such as µa and µs’ w
are saved in a user generated .log file. A control signal is then sent to the DCS to
reinitiate the entire cycle.

Data acquisition times are modifiable based on input

parameters. Specific acquisition times for each protocol are detailed in the following
chapters.
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2.4

2

Derivation

To determine the absolute oxygen
2

S

2)

2

is calculated from tissue oxygen saturation (StO2
D S

’

w

2

is equal to the blood flow

times the arterio-venous oxygen difference:
 O  BF  ([O ]  [O ] )
V
2
2 a
2 v

(13)

where [O2]a is the arterial oxygen concentration, and [O2]v is the venous oxygen
concentration. The percentage of oxygen extracted, or the oxygen extraction fraction
(OEF) can be defined as: OEF = ([O2]a – [O2]v)/[O2]a. Com
q

2

w

can be defined by the following equation:
 O  OEF  BF  ([O ])
V
2
2
a
2,

(14)

rOEF, rBF, r[O2]a) can be determined by

dividing by the respective baseline value, so Eq. 14 becomes:
 O  rOEF  rBF  (r[O ] )
rV
2
2 a

(15)

Making the assumption that [O2]a does not change [13], the equation is reduced to:
(16)

rBF  rOEF  rBF

OEF is related to tissue oxygen saturation by the following:
OEF 

(Sa O 2  S t O 2 )
( γ  Sa O 2 )

where SaO2 and StO2

(17)
γ

percentage of blood volume contained in the venous compartment of the vascular system
[65, 66]

γ
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constant (see Section

6.3). If SaO2 is also assumed to be a constant 100%, which has been found to be a
reasonable approximation [13, 67], then Eq. 17 becomes:
rOEF 

Substituting this into Eq. 16

2

(1  S t O 2 )
(1  S t O 2baseline)

(18)

can be calculated as:

 O  rBF
rV
2

(1  S t O 2 )
(1  S t O 2baseline)

(19)

StO2 is measured directly with NIRS, and rBF is measured directly with the DCS, thus
2

can be measured by the hybrid instrument.
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CHAPTER 3: MEASUREMENT PROTOCOL

The measurement protocol is divided into three distinct sub-protocols: venous
occlusion for baseline absolute BF calculation, arterial occlusion for baseline absolute
2

calculation, and the exercise protocol for modulation of BF,

2,

and StO2. This

chapter is divided as follows: First, there is an introduction to the overall measurement
protocol in Chapter 3.1. Specifics of the calibration calculations are addressed in Chapter
3.2, and the exercise protocol is described in Chapter 3.3. Finally, the gating algorithm
used during exercise is described in Chapter 3.4.

3.1 Measurement Protocol Overview
Following the methods detailed in previous work [1, 55, 68], three different protocols
were used in this study to obtain absolute BF, StO2, and

2

in the forearm flexors

during exercise. First, venous occlusion at 50 mmHg was applied on upper arm to obtain
absolute baseline BF [1]. Second, arterial occlusion at 240 mmHg was applied to obtain
absolute baseline

2

[55]. Third, muscle BF and

2

were manipulated by 5 minutes

of rhythmic handgrip exercise at a fraction of the maximal voluntary contraction (MVC)
[68] to test the capabilities of using the hybrid optical device for quantifying absolute BF
and

2

continuously during exercise. During all protocols, a black, flexible fiber-optic

probe (see Figure 4) was taped to the skin surface above the forearm flexor muscles
(flexor digitorum superficialis/profundus).

This probe allowed for transmission of

photons to the tissue via source fibers, and detection of backscattered photons at the
tissue surface via detector fibers.
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Before the optical probe was fixed, subjects were instructed to lie supine with the right
arm extended, slightly elevated above heart level (< 20°). Elevation prevents pooling of
the blood and facilitates venous return (see Figure 7). Elbow flexion was kept as close to
0° as possible. Resting blood pressure was obtained using an automatic monitor (Omron
HEM-80, Kyoto), and skin/adipose tissue thickness at the probe site was measured with
skinfold calipers (Lange 85300, TX).
First, individual MVC was determined for each subject by incremental isotonic
handgrip exercise. Healthy subjects squeezed a handgrip device on a dynamometer (BTE
PrimusRS, MD) through a distance of 5 cm for an increasing load until they were unable
to perform the task. Initial load was set at ~20 N·m with an incremental increase of ~5
N·m. In most subjects, MVC could be determined within 4 contractions, minimizing the
effect of fatigue or potentiation. Following MVC testing, the dynamometer load was
reduced to a fraction of the MVC, and subjects completed a very brief training period (<
15 repetitions) to familiarize themselves with the contraction rhythm during the exercise
protocol. A visual metronome on the dynamometer monitor aided subjects in keeping
pace, and subjects were able to complete the exercise protocol at the set rhythm without
difficulty. Subjects were then instructed to rest while the optical probe was taped to the
right forearm and a fast-inflating automatic tourniquet cuff (Zimmer ATS 1000, IN) was
placed on the right upper arm just above the elbow.
During the venous occlusion protocol, 1 minute baseline measurement was recorded,
followed by three repetitions of 10 s occlusion (50 mmHg) separated with 30 s rest. For
the arterial occlusion protocol, another 1 min baseline was recorded, followed by a 3minute arterial occlusion (240 mmHg). Following the release of the arterial cuff, 5
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minutes recovery data were collected to ensure hemodynamic recovery to baseline. After
baseline had been reestablished, subjects performed 5 minutes handgrip exercise
following the rhythm described above. Five minutes recovery data were then recorded.
Data acquisition parameters and protocols are discussed in detail in the following
sections.

Figure 7. Arm Positioning and Probe Fixation during Protocol
During all protocols, subject was supine with the right arm extended slightly elevated above heart level (<
20°) to prevent pooling and facilitate venous return. The hand maintained the grip position, around the
dynamometer attachment. The hybrid optical probe (see Figure 4) was taped to the forearm flexor muscles
(flexor digitorum superficialis/profundus) following MVC test, prior to occlusions.
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3.2 Calibration of Relative Signals with Absolute Baseline BF and

2

The relative blood flow (rBF) signal acquired from the DCS was calibrated in this
study by using venous occlusion in conjunction with NIRS measurement.

Venous

occlusion plethysmography is a widely accepted method for determining peripheral blood
flow [15, 69], and has been used frequently in recent years with NIRS techniques [1, 28,
53, 70]. This technique has been applied on both resting and exercising muscle, and has
been validated against the more conventional standard of strain-gauge plethysmography
[1, 28]. During venous occlusion, a fast-inflating tourniquet cuff is applied to the upper
arm just above the elbow and inflated to a pressure greater than the venous pressure, but
lower than diastolic arterial pressure. Pressure between 30 – 60 mmHg gives the most
reproducible results [71], and the most common convention is to use 50 mmHg (used in
this study). By inflating the cuff to this pressure, venous outflow is occluded while
arterial inflow is permitted, causing a total blood volume increase in the arm. This is
recorded by NIRS measurements as an increase in [tHb] (see Figure 8). The initial rate
of increase (~5 s) is directly proportional to the arterial inflow. BF is calculated by the
following equation [72]:

BF 

1 d [ tHb]

C
dt

(20)

where C is the hemoglobin concentration of whole blood. In this study, a standard value
of 14.1 g/dL [73] was used for C, but individual concentrations may be measured
invasively through blood samples, obtained from patient records, or measured
noninvasively via pulse CO-oximetry (Masimo, Inc., CA) [74]. [tHb] is converted from
molar concentration to blood volume by multiplying by the molecular weight of
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hemoglobin (64,458 g/mol) [75], and dividing by C. Absolute BF is expressed in units of
ml blood per 100 ml tissue per minute [ml/100 ml/min].

Figure 8. Slope Fitting during Venous Occlusion for Absolute BF Calculation
The [tHb] increase induced by 50 mmHg venous occlusion is fit with linear regression. The initial slope of
the fitted line (~5 s) is indicative of the muscle BF (see Eq. 20). Vertical lines indicate application and
release of venous pressure.

During the venous occlusion protocol, only NIRS data (without DCS) were collected
at a sampling rate of 3.7 Hz. Only amplitude data were used in order to eliminate noise
contributed by the phase component of the acquired data (see Section 2.1). Preliminary
testing showed that this high sampling rate was adequate to precisely fit the [tHb] curve
during venous occlusion measurements. One minute of baseline data were recorded prior
to any venous occlusion. After baseline data acquisition, three venous occlusions were
performed for 10 s each, with 30 s rest between each occlusion, and a 30 s recovery
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period following the last occlusion. The baseline BF was then determined by averaging
the three venous occlusion measurements.
Relative

2

(r

2,

derived in Section 2.4) was calibrated in this study by observing

the rate of oxygen desaturation ([HbO2] – [Hb]) during the first 60 s of arterial occlusion
[55]. During arterial occlusion, a fast-inflating tourniquet cuff is applied to the upper arm
just above the elbow and inflated to a pressure significantly greater than systolic arterial
pressure (240 mmHg used in this study). This maneuver causes a total interruption of the
blood supply (i.e. oxygen supply), while the tissue continues to consume oxygen.

2

is

then proportional to the rate of oxygen desaturation ([HbO2] – [Hb]), measured by NIRS
(see Figure 9).

Molar concentration of hemoglobin is converted to O2 volume by

multiplying by the O2 molecular weight (32 g/mol) and the ratio of O2 to hemoglobin
(4:1), and dividing by the O2 density (1.429 g/L). Tissue volume is converted to mass by
dividing by the muscle density (1.04 kg/L) [53].

2

is then expressed as ml O2 per 100

g muscle per minute [ml O2/100 g/min].
For the arterial occlusion protocol, alternating NIRS measurements were combined
with DCS measurements.

While not used directly to calculate baseline

2,

DCS

measurements provided validation that BF was adequately occluded. DCS sampling time
was ~300 ms while NIRS sampling time was ~400 ms (~700 ms total sampling time per
data point). The arterial occlusion protocol consisted of 1 minute resting baseline data,
followed by a 3-minute arterial occlusion. Only the first 60
w

2

(see Figure 9). Following release of the

tourniquet, 5 minutes of resting recovery data were recorded.
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Figure 9. Slope Fitting during Arterial Occlusion for Absolute

2

Calculation

The saturation decrease induced by 240 mmHg arterial occlusion is fit with linear regression. The slope of
the fitted line during the first 60 s of occlusion

2.

Vertical lines indicate

application and release of arterial pressure.

3.3 Exercise Protocol
Following the release of the tourniquet and 5 minutes recovery from the arterial
occlusion protocol, the software gating algorithm was engaged (see Section 3.4), and
young healthy subjects (n = 9) were instructed to perform 5 minutes of handgrip exercise
at 25% MVC (6.8 ± 0.6 N·m) at a rate of 1s contraction (~0.5 s to contract, ~0.5 s to
release) followed by 1 s rest.

At this submaximal exercise intensity, muscle is

sufficiently

/

2/StO2

without inducing obvious post-

exercise hyperemic response [68]. This exercise protocol is in line with many other
similar studies [1, 76, 77] to allow a basis for comparison of results. Each subject
therefore performed 150 contraction cycles. Data were acquired during the relaxation
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phase of exercise. Sampling times were the same as used for the arterial occlusion
protocol (~300 ms DCS, ~400 ms NIRS, for ~700 ms total). Following exercise, the
gating algorithm was disengaged, and 5 minutes of recovery kinetics were recorded.
For the fibromyalgia subjects (n = 11) and their healthy control counterparts (n = 13),
a modified exercise protocol was used. Differing from the exercise protocol described
above, dynamic exercise for these subject populations was performed at 50% MVC, at a
rate of 15 contractions/minute (1 s contract, 1 s release, 2 s rest for each contraction
cycle). Preliminary testing in 3 subjects in this older subject population showed that the
slower rhythm of this contraction cycle was easier to follow than the 30
contractions/minute rhythm used in the young healthy population. To account for the
slower cycle, the delay time used in the gating algorithm was 100 ms. Other data
acquisition times were the same as that described in the preceding sections.

3.4 Embedded Gating Algorithm to Reduce Motion Artifact
Previous work in the field of diffuse correlation spectroscopy (DCS) has been limited
by the fact that muscle contraction produces a signal artifact which can significantly
overestimate flow [50].

To eliminate this motion artifact, a gating algorithm was

embedded into the DCS data acquisition control software. This algorithm read analog
voltage output signals from the dynamometer to determine periods of contraction and
relaxation in the rhythmic exercise cycle. Once the output voltage exceeded a specified
threshold indicating the transition from contraction (low voltage) to relaxation (high
voltage), a trigger was initiated. The trigger allowed for a short delay (50 ms, specified
by user) to account for any residual motion, then initiated data acquisition. After a frame
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of data was recorded and stored, the software waited for the next rising edge in the
dynamometer signal to reinitiate measurement. Input and control signals for the gating
algorithm are shown in Figure 10.

Figure 10. Input and Control Signals for Gating Algorithm
The output signals from the dynamometer and the software-generated signals that control the gating
algorithm are shown. The dynamometer voltage mirrors the handgrip position, indicating contraction
status of the muscle. Once the dynamometer voltage passes a threshold on the rising edge, the algorithm
generates a trigger signal, which injects a small delay (to account for residual muscle tension/contraction)
before initiating data acquisition. Data acquisition occurs between contractions, while the muscle is at rest.
Following a data acquisition sequence, the algorithm pauses, waiting for the next rising edge in the
dynamometer voltage.
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CHAPTER 4: VALIDATION IN YOUNG HEALTHY SUBJECTS
The measurement protocol developed in this study was first used in a young healthy
population and validated against previous literature results. Presentation of the results is
ordered in the following manner. First, the physical characteristics of the population are
described in Chapter 4.1. The effect of the embedded gating algorithm is then evaluated
in Chapter 4.2. Next, the typical individual hemodynamic/metabolic response during the
course of the entire measurement protocol is presented in Chapter 4.3, as well as the
average results of BF,

2,

and StO2 for all subjects during exercise in Chapter 4.4.

4.1 Young Healthy Subject Physical Characteristics
Nine healthy subjects (5 males, 4 females) volunteered to participate in this study
following written consent in accordance with the University of Kentucky Institutional
Review Board guidelines. Physical characteristics for the sample population were (mean
± SE) age 24.6 ± 0.6 yr, height 167.9 ± 2.5 cm, and weight 73.8 ± 8.2 kg (BMI 22.9 ±
3.2).

Resting systolic arterial pressure was 116.2 ± 3.1 mmHg, skin/adipose tissue

thickness (ATT) was 1.5 ± 0.2 mm, and MVC was 27.3 ± 0.6 N·m.

4.2 Effect of Gating Algorithm on Motion Artifact
Preliminary experimentation showed that the software gating algorithm was effective
in removing a majority of the noise associated with motion artifact. Figure 11 shows
D S

w

αDB) raw signals acquired during exercise both without (Figure 11a),

and with (Figure 11b) the gating algorithm. The two trials were performed on the same
subject, at the same rate and intensity (25% MVC) as the exercise protocol for young
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healthy subjects detailed in Section 3.3. The trials were separated by several minutes (>
6 minutes) to ensure BF and oxygenation recovery to baseline. The results clearly
demonstrate the efficacy of the algorithm at removing noise due to motion artifact from
the raw data signal.

Figure 11. Motion Artifact Reduction with Application of Gating Algorithm
Raw DCS data acquired during exercise protocol (see Section 3.3). Panel (a) shows data collected without
the gating algorithm running. Panel (b) shows data collected with the application of the algorithm. Raw
data are

αDB, the blood flow index. The vertical lines indicate the beginning and end of the

exercise protocol.

4.3 Typical Individual Response
The typical muscle hemodynamic response for the entire protocol is shown for a single
subject in Figure 12. Vertical lines denote the beginning and ending of physiological
manipulations (occlusions, exercise). Dark bold lines superimposed on the data signals
indicate slope fitting during both venous and arterial occlusions. During the venous
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occlusions (VO), [tHb] increased at a rate proportional to the arterial inflow (see Section
3.2). Baseline BF for this subject obtained from the three venous occlusions was 2.48 ±
1.14 ml/100 ml/min. During arterial occlusion (AO), [tHb] remained constant, while the
desaturation ([HbO2] – [Hb]) decreased at a rate proportional to

2

(see Section 3.2).

Correspondingly, there was a noticeable decrease in tissue oxygen saturation (StO2), and
the rBF signal from the DCS decreased to near zero. Baseline

2

obtained from arterial

occlusion was 0.11 ml O2/100 g/min (5.04 µmol O2/100 g/min). During the exercise
2

increased, corresponding to a decrease in StO2, and an increase in rBF to

satisfy the metabolic demand. The absolute BF,

2,

and StO2 during exercise are

shown in Figures 13, 14, and 15 for the same subject.

4.4 Average Population Response
All subjects demonstrated similar trends during occlusion and exercise.

Resting

baseline BF for the 9 subjects (mean ± SE) obtained via venous occlusion was 1.76 ±
0.40 ml/100 ml/min. Baseline
O2/100 /

5 62 ± 1 03 μ

2

obtained by arterial occlusion was 0.12 ± 0.02 ml

2/100

g/min), and baseline StO2 was 68.0 ± 1.0%. To

clearly see the general response to exercise, the filtered BF,

2,

and StO2 signals were

averaged across the subject population at 10 s time intervals throughout the protocol.
The averaged exercise data are shown in Figures 16, 17, and 18. Pre-exercise BF value
was 1.76 ± 0.42 ml/100 ml/min, determined as the average of data points 30 s before the
beginning of exercise. This pre-exercise BF does not differ significantly from resting BF,
indicating that there was no residual hyperemic response from arterial occlusion. Preexercise

2

value was 0.11 ± 0.03 ml O2/100 g/min, the same as the average resting
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baseline value, and pre-exercise StO2 value was 71.9 ± 1.9%. During exercise, BF
increased rapidly during the first few minutes, then increased following a more
exponential pattern to a gradual plateau. The

2

dynamics during exercise mirrored

this response with initial linear increase followed by exponential increase to a gradual
plateau. Plateau values were determined as the average of data points 30 s before the end
of exercise. For the 9 subjects, average plateau BF was 8.93 ± 2.81 ml/100 ml/min,
plateau

2

was 0.57 ± 0.13 ml O2/100 g/min, and plateau StO2 was 64.0 ± 2.2%.
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Figure 12. Hemodynamic Response in a Single Subject during Entire Protocol
Data collected for a single subject for the entire measurement protocol. Panel (a) shows [HbO2], [Hb], and
[tHb] response during three 50 mmHg venous occlusions (VO). The vertical lines denote the beginning
and end of each occlusion. Panel (b) shows [HbO2], [Hb], [tHb], desaturation ([HbO2] – [Hb]), StO2, and
rBF responses during arterial occlusion (AO) and exercise (Ex). The pairs of vertical lines denote the
beginning and end of AO and Ex.
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Figure 13. Absolute BF Response during Exercise in a Single Subject
The absolute BF response in an individual subject during exercise. The vertical lines denote the beginning
and end of exercise. Residual noise prior to exercise may be caused due to involuntary muscle contractions
in preparation for physical activity before the gating algorithm had been initiated.

Figure 14.
T

2

2

Response during Exercise in a Single Subject

response in an individual subject during exercise.

The vertical lines denote the

beginning and end of exercise. Residual noise prior to exercise may be caused due to involuntary muscle
contractions in preparation for physical activity before the gating algorithm had been initiated.
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Figure 15. StO2 Response during Exercise in a Single Subject
The StO2 response in an individual subject during exercise. The vertical lines denote the beginning and end
of exercise. The slight increase in StO2 prior to exercise may be caused by increased flow from involuntary
muscle contractions in anticipation to exercise, before oxygen demand increased.

Figure 16. Average Population Absolute BF Response during Exercise
The average absolute BF response of 9 healthy young subjects during exercise. For clarity, data were
filtered and averaged at 10 s time intervals. The vertical lines denote the beginning and end of exercise.
Average pre-exercise BF value was 1.76 ± 0.42 ml/100 ml/min, determined as the average of data points
30 s before onset of exercise. Plateau BF value was determined as the average of data points 30 s before
the end of exercise. For the 9 subjects, average plateau BF was 8.93 ± 2.81 ml/100 ml/min.
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Figure 17.
T

2

2

Response during Exercise

response of 9 healthy young subjects during exercise. For clarity, data were

filtered and averaged at 10 s time intervals. The vertical lines denote the beginning and end of exercise.
Average pre-exercise

2

value was 0.11 ± 0.03 ml O2/100 g/min, determined as the average of data points

30 s before onset of exercise. Plateau

2

value was determined as the average of data points 30 s before

the end of exercise. For the 9 subjects, average plateau

2

was 0.57 ± 0.13 ml O2/100 g/min.

Figure 18. Average Population StO2 Response during Exercise
The average StO2 response of 9 healthy young subjects during exercise. For clarity, data were filtered and
averaged at 10 s time intervals. The vertical lines denote the beginning and end of exercise. Average preexercise StO2 value was 71.9 ± 1.9%, determined as the average of data points 30 s before onset of exercise.
Plateau StO2 value was determined as the average of data points 30 s before the end of exercise. For the 9
subjects, average plateau StO2 was 64.0 ± 2.2%.
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CHAPTER 5: APPLICATION TO DISEASE POPULATION

Chapter 5 outlines the application of the developed technique to investigation of
fibromyalgia, a clinical disease of unknown etiology. Both subjects diagnosed with
fibromyalgia, as well as age-matched healthy controls were investigated. The chapter
opens with a review of the disease, and studies that have previously assessed flow and
metabolism in affected populations in Chapter 5.1. The subject population demographics
are then detailed in Chapter 5.2, and the results are presented in Chapter 5.3.

5.1 Hemodynamics and Metabolism in Fibromyalgia
Fibromyalgia (FM) is a chronic pain syndrome, characterized by widespread muscle
pain and stiffness, aching, and fatigue.

FM has been generally described as

musculoskeletal pain in the absence of other apparent organic disease [78], and in 1990
the American College of Rheumatology committee established diagnosis criteria
including history of widespread pain, and tenderness to digital palpitation at 11 of 18
specified tender sites [79]. FM affects approximately 2% of the U.S. population, and is
approximately 7 times more prevalent in women than in men [80]. The pathophysiology
of FM is unknown, but likely involves neurological, neuroendocrine, musculoskeletal,
and psychological components [81].
FM treatments tend to be only partially effective, and target symptomatic relief,
rather than the underlying cause. Therapies include pharmacological management [6], as
well as exercise [82], hyberbaric oxygen therapy [83], and nitric oxide stimulants [84]. A
commonality among partially effective treatments is a vasodilatory effect.
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This, in

addition to the qualitative description of FM pain as being similar to pain in muscles
following heavy exercise or anaerobic metabolism, has led to the hypothesis that the pain
of FM may be caused in part by vasomotor dysregulation or metabolic abnormality [84].
Although challenged, several studies have found apparent impairments in BF [5, 8590] and metabolism [91-95] of FM subjects. These studies have independently explored
hemodynamic/metabolic parameters using Doppler ultrasound [5], laser Doppler [86, 90],
biopsy [85, 89, 91, 92], dynamic fluorescence videomicroscopy [87], laser fluxmetry
[88], electrodes [93], and 31P-MRS [95]. While some studies have used these methods in
combination to investigate BF and metabolism in resting muscle [86, 89]
2,

and StO2 noninvasively during exercise

in skeletal muscle of FM subjects.
The ability to

monitor

multiple hemodynamic and

metabolic

parameters

simultaneously in response to exercise stimulus may open research options and have the
potential to help elucidate the underlying mechanisms in FM and thus lead to more
effective methods of treatment.

Using the method developed in this thesis, eleven

women diagnosed with FM and thirteen
2,

-

w

and StO2 changes during 50% MVC dynamic handgrip exercise.

5.2 Physical Characteristics of Subjects
Initially, eleven subjects diagnosed with FM and thirteen age-matched healthy controls
(HC) were voluntarily recruited to participate in this study following written consent in
approval with the University of Kentucky Institutional Review Board guidelines. One
FM subject recruited for evaluation was excluded from data analysis due to excessive
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ATT thickness (10 mm) which affected light penetration into the muscle. Therefore, data
are presented for only 10 subjects. Only female subjects were recruited for this study.
Physical characteristics for the sample population (mean ± SE) are given in Table 1. In
all parameters except MVC, no significant differences were found between populations.
The MVC for HC subjects was slightly lower than that for young healthy subjects, while
the MVC of FM subjects was significantly lower than both healthy populations.

Table 1. Physical Characteristics of Fibromyalgia (FM) Subjects
and Age-Matched Healthy Controls (HCs)

p-value
’ -test)

Parameter

HC (n = 13)

FM (n = 10)

Age (yrs)

57 ± 1.2

60 ± 2.3

0.2163

BMI

25.1 ± 0.8

24.4 ± 1.1

0.5849

Syst. BP (mmHg)

123.7 ± 3.9

125.4 ± 3.1

0.7354

ATT (mm)

2.9 ± 0.4

2.9 ± 0.4

0.9945

MVC (N·m)

24.14 ± 0.84

15.31 ± 1.23

<0.0001*

5.3 Typical Individual Response
The typical muscle hemodynamic/metabolic response for the exercise protocol is
shown for a single HC and FM subject in Figures 19, 20, and 21. Vertical lines denote
the onset and end of exercise. Pre-exercise BF, measured as the average of points 30 s
before the onset of exercise was 1.60 and 1.62 ml/100 ml/min for the HC and FM
subjects, respectively.

-

2

was 0.03 and 0.04 ml O2/100 g/min, and pre-

exercise StO2 was 70.1 and 72.3%. Plateau BF, measured as the average of points 30 s
before the end of exercise was 10.88 and 3.16 ml/100 ml/min for HC and FM subjec
w

2

was 0.30 and 0.12 ml O2/100 g/min, and StO2 was 59.9

and 68.7%. D

2

increased, corresponding to a decrease in

StO2, and an increase in BF to satisfy the metabolic demand.
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Figure 19. Individual HC and FM BF Response to Exercise
Raw absolute BF data in response to exercise for both a single HC subject and FM subject are shown.
Vertical lines indicate the beginning and end of exercise. Pre-exercise BF value was 1.60 ml/100 ml/min
for the HC subject and 1.62 ml/100 ml/min for the FM subject. Plateau BF values were 10.88 and 3.16
ml/100 ml/min for the HC and FM subjects, respectively.

Figure 20.
Raw

2

2

Response to Exercise

data in response to exercise for both a single HC subject and FM subject are shown.

Vertical lines indicate the beginning and end of exercise. Pre-exercise

2

value was 0.03 ml O2/100

g/min for the HC subject and 0.04 ml O2/100 g/min for the FM subject. Plateau
0.12 ml O2/100 g/min for the HC and FM subjects, respectively.
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2

values were 0.30 and

Figure 21. Individual HC and FM StO2 Response to Exercise
Raw StO2 data in response to exercise for both a single HC subject and FM subject are shown. Vertical
lines indicate the beginning and end of exercise. Pre-exercise StO2 value was 70.1% for the HC subject and
72.3% for the FM subject. Plateau StO2 values were 59.9 and 68.7% for the HC and FM subjects,
respectively.

5.4 Average Population Response
Subject data from both demographics demonstrated similar trends during occlusion
j

’

StO2

2

data were not used

following the 380 s time point, due to signal contamination from excessive movement by
the subject

T
2,

and StO2 signals were averaged across the

subject population at 10s time intervals throughout the protocol. The averaged exercise
data are shown in Figures 22, 23, and 24
2,

-

and StO2 values are summarized in Table 2.
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Figure 22. Average HC and FM Population BF Response to Exercise
The average absolute BF response to exercise of 10 subjects with fibromyalgia (FM) and 13 age-matched
healthy controls (HC). For clarity, data were filtered and averaged at 10 s time intervals. The vertical lines
indicate the beginning and end of exercise. Average pre-exercise BF value, determined as the average of
data points 30 s before the onset of exercise, was 3.19 ± 1.03 ml/100 ml/min for the HC subjects and 2.63 ±
0.71 ml/100 ml/min for the FM subjects (p = 0.444). Plateau BF values were determined as the average of
data points 30 s before the end of exercise. Plateau BF value, determined as the average of points 30 s
before the end of exercise was 10.71 ± 3.91 ml/100 ml/min for HC subjects and 4.83 ± 1.42 ml/100 ml/min
for FM subjects (p = 0.018).

j

averaging, due to signal contamination.
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’

were no longer used for

.

Figure 23.
T

2

2

Response to Exercise

response to exercise of 10 subjects with fibromyalgia (FM) and 13 age-matched

healthy controls (HC). For clarity, data were filtered and averaged at 10 s time intervals. The vertical lines
indicate the beginning and end of exercise. Average pre-exercise

2

value, determined as the average of

data points 30 s before the onset of exercise, was 0.07 ± 0.02 ml O2/100 g/min for the HC subjects and 0.08
± 0.03 ml O2/100 ml/min for the FM subjects (p = 0.690). Plateau
average of data points 30 s before the end of exercise. Plateau

2

2

values were determined as the

value, determined as the average of

points 30 s before the end of exercise was 0.35 ± 0.09 ml O2/100 g/min for HC subjects and 0.16 ± 0.05 ml
O2/100 g/min for FM subjects (p = 0.002).

j

for averaging, due to signal contamination.
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’

were no longer used

Figure 24. Average HC and FM Population StO2 Response to Exercise
The average absolute StO2 response to exercise of 10 subjects with fibromyalgia (FM) and 13 age-matched
healthy controls (HC). For clarity, data were filtered and averaged at 10 s time intervals. The vertical lines
indicate the beginning and end of exercise. Average pre-exercise StO2 value, determined as the average of
data points 30 s before the onset of exercise, was 68.0 ± 1.6% for the HC subjects and 67.9 ± 0.93% for the
FM subjects (p = 0.947). Plateau StO2 values were determined as the average of data points 30 s before the
end of exercise. Plateau StO2 value, determined as the average of points 30 s before the end of exercise was
57.1 ± 3.9% for HC subjects and 63.3 ± 1.3% for FM subjects (p = 0.013). Note that at the dashed line, one
j

’

were no longer used for averaging, due to signal contamination.
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Table 2.

2,

and StO2 Results for HC and FM Populations

p-value
’ -test)

Parameter

HC (n = 13)

FM (n = 10)

Baseline BF
(ml/100 ml/min)

2.27 ± 0.52

2.42 ± 0.76

0.876

0.16 ± 0.05

0.10 ± 0.04

0.346

Baseline StO2
(%)

69.1 ± 1.0

69.2 ± 0.9

0.920

Pre-exercise BF
(ml/100 ml/min)

3.19 ± 1.03

2.63 ± 0.71

0.444

2
(ml O2/100 g/min)

0.07 ± 0.02

0.08 ± 0.03

0.690

Pre-exercise StO2
(%)

68.0 ± 1.6

67.9 ± 0.93

0.947

Plateau BF
(ml/100 ml/min)

10.71 ± 3.91

4.83 ± 1.42

0.018*

0.35 ± 0.09

0.16 ± 0.05

0.002*

57.1 ± 3.9

63.3 ± 1.3

0.013*

2

(ml O2/100 g/min)

2

(ml O2/100 g/min)
Plateau StO2
(%)
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CHAPTER 6: DISCUSSION AND CONCLUSIONS

This chapter begins with a discussion of the results from the two studies: the
validation of the protocol in young healthy subjects (Chapter 6.1), and the application of
the technique to a fibromyalgia population (Chapter 6.2). A comparison of baseline BF
2 S 2

w

6.3. Next potential sources of error and challenges to the measurement technique are
discussed in Chapter 6.4, including the influence of myoglobin on the optical signal, the
influence of skin and adipose tissue, and the error introduced by assuming constant
γ T

S/D S

compared to alternate modalities are reviewed in Chapter 6.5, and ideas for improvement
of the gating algorithm are introduced in Chapter 6.6. Finally, a summary of conclusions
regarding the reliability and applicability of the technique is given in Chapter 6.7.

6.1 Validation Results from Young Healthy Subjects Compared to Literature
The feasibility of this technique for monitoring absolute hemodynamic and metabolic
responses in exercising muscle was assessed by comparison to results found in the
literature using a variety of measurement techniques. For validation of plateau values
towards the end of exercise, studies were investigated that employed dynamic forearm
exercise within the same intensity range as the protocol described in Chapter 3.
Comparisons for BF and

2

are presented in Table 3. Because the literature studies

with similar exercise protocol and intensity do not generally report StO2
2

data are used for comparison.
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As StO2

2

2

validation serves to corroborate StO2 results. In addition, NIRS

measurements of StO2 have been previously validated with other techniques by many
groups, including O2 electrodes [96],

133

Xenon clearance [97], and indocyanine green

[98-100].
The

2

results were consistent with previously reported baseline

values of BF [1, 8, 28, 29, 53, 54, 70, 76]

2

[1, 8, 28, 29, 53, 70, 76], as are the

plateau values [1, 8, 76] T

2

changes

during exercise also agree with the general profiles found in previous exercise studies
[68, 101, 102].

One disagreement between these response profiles
/

2

value during the recovery period following

exercise, relative to the resting baseline value prior to exercise (see Figures 16, 17, and
18). While the origin of this shift has not yet been specifically identified, it is possible
that it may be due to increased temperature at the probe site due to accumulated heat from
exercising muscle trapped by the adhesive tape, which may increase Brownian motion
and flow. Recent preliminary studies investigating the use of thinner adhesives such as
Tegaderm®, as well as more open probe designs allowing for greater radiation of heat
through the skin surface suggest that the shift may be mitigated by such intervention.
Alternatively, it is possible that the light pressure from probe contact may induce a
gradual hyperemic response [103, 104]. The shift may also be due to flow response
differences between the microvasculature and large vessels measured by different
modalities (e.g. DCS versus Doppler ultrasound) in different studies.
investigation is necessary to verify the cause.
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Further

Table 3. Comparison of Validation Study Results to Literature

Study

Methods for
measuring
BF,
2

†

Resting BF
(ml/100ml/
min)

Exercise BF
(ml/100ml/
min)

Resting
2
(ml O2/
100g/min)

Exercise
(ml O2/
100g/min)

(Van
Beekvelt
2001)[28]

NIRS + VO,
NIRS + AO
(n = 26)

0.72 ± 0.32

n/a

0.11 ± 0.03

n/a

†

(DeBlasi
1994)[1]

NIRS + VO
(n = 11)

1.9 ± 0.8

8.2 ± 2.9

0.10 ± 0.03

0.54 ± 0.24

†

(Harel
2008)[53]

NIRS + VO
(n = 25)

2.55 ± 0.10

n/a

n/a

n/a

††

NIRS + VO,
NIRS + AO
(n = 27)

0.719 ± 0.063

n/a

0.106 ± 0.006

n/a

NIRS + O2
inspiration
(n = 6)

2.35 ± 1.11

n/a

n/a

n/a

3.10 ± 0.27

7.10 ± 0.76

0.12 ± 0.01

0.51 ± 0.05

2.54 ± 0.23

9.20 ± 1.08

~0.1

~0.75

2.9
(0.09 – 0.52)

n/a

0.24 ± 0.07

n/a

1.76 ± 0.42

8.93 ± 2.81

0.11 ± 0.03

0.57 ± 0.13

(Van
Beekvelt
1999)[105]
†

(Edwards
1993)[54]
††

(Zelis
1974)[77]
††

(Arnold
1990)[76]
†

(Mottram
1955)[29]
††

(Gurley
2012 –
present
study)

†

Strain gauge
VO,
blood samples
(n = 22)
Strain gauge
VO,
blood samples
(n = 8)
Strain gauge
VO,
blood samples
(n = 16)
NIRS/DCS +
VO,
NIRS/DCS +
AO
(n = 9)

Study results are represented as (mean ± SD).

2

††

Study results are represented as (mean ± SE). Results

presented without ranges are inferred from figures (i.e., values were not specifically stated in text).
Measurements are on forearm flexor muscles of healthy adults. Studies including exercise data are for
protocols which involve light/moderate rhythmic exercise at a similar intensity to that presented in the
present study. Venous and arterial occlusion methods are represented as VO and AO, respectively. ‘ / ’
not applicable.
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6.2 Results from Fibromyalgia Study
Tissue blood flow, oxygenation, and metabolism have all been previously investigated
in fibromyalgia populations by means of Doppler ultrasound [5], laser Doppler [86, 90],
biopsy [85, 89, 91, 92], dynamic fluorescence videomicroscopy [87], laser fluxmetry
[88], O2 electrodes [93], and 31P-MRS [95]. Findings are controversial, and no study has
investigated all three parameters (i.e.,

2,

and StO2) simultaneously, noninvasively,

and continuously during exercise. The present study investigated the feasibility of using
a novel hybrid optical instrument and calibration protocol to investigate such parameters
in FM and age-matched HC subjects during exercise. The results indicate that the
applied technology has the potential to differentiate group differences and may fill a void
in fibromyalgia research that other technologies cannot.
All subjects’
2

displayed similar trends in response to handgrip exercise

increased in response to metabolic demand induced by exercise, and StO2

correspondingly decreased as more oxygen was consumed from the tissue. In the study,
no significant difference was found between HC and FM populations

2,

and

StO2 when comparing data points from 30 s of resting baseline data before exercise, but a
significant difference was evident in all three variables from the last 30 s of exercise (see
Section 5.4).

In addition, the physiological profiles (see Figures 22, 23, and 24)

qualitatively suggest a significant difference in
exercise between the two groups.

2,

and StO2 response to 50% MVC

Variables recover quickly following the end of

exercise, suggesting that it may be difficult to observe differences between populations
by only monitoring post-exercise data [5], further emphasizing the importance of
quantifying muscle hemodynamic and metabolic responses during exercise.
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The significant difference in plateau BF between HC and FM populations evident in
the study results shows that FM subjects do not reach peak flows as high as HC subjects
in response to the same

T

w

2

increase and lower

StO2 decrease in FM subjects during exercise indicate that there may also be some
deficiency in oxygen utilization, which may be associated with poor mitochondrial
function [106].
While the data presented shows that there is lower increase in

2,

and lower

decrease in StO2 in FM subjects in response to exercise, it should be noted that there is a
significant difference in the initial MVC between the groups. Consequently, the two
groups had differing energy outputs during the exercise period.
w

2,

w

w

which additionally translates

to a lower flow requirement for the working muscle [107]. The difference in MVC may
be attributed to deconditioning due to inactivity or the disease state itself. Although the
FM subjects in this study were fairly fit, and had relatively comparable activity levels to
the HC subjects, specific activities were not evaluated. For example, it is possible that
the forearm muscle groups were less utilized than muscles of the leg

j

’

normal exercise routine, and were therefore more subject to deconditioning. It is also
possible

j

’ gave varying levels of effort within the population. To ensure each

subject was contracting at maximal voluntary effort, an interpolated twitch technique may
be used in future [108]. T
2,

w

w

or StO2. However, the extent to which this difference in MVC impacts the

significance of the difference observed in the outcome variables has not yet been
clarified, and requires further rigorous statistical analysis.
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To fully understand the

differences between HC and FM exercise response, groups of subjects with similar MVC
should be tested to eliminate the effect of deconditioning that is commonly seen in FM
patients [109]. In addition, larger groups of subjects should be recruited to ensure the
significance of population differences and reduce the magnitude of the error bars in
Figures 22, 23, and 24.

6.3 Comparison of Young and Older Healthy Subjects
2,

and StO2 in both the

young and older healthy controls (Table 4) shows that values were very similar between
healthy populations. This is in line with the findings of previous studies investigating
hemodynamics/metabolism in response to aging [110, 111]. MVC was slightly, though
not significantly lower in older HC, while the other parameters showed no significant
differences. The plateau values cannot be reasonably compared between old and young
healthy subjects due to the differing intensity exercise protocols (50% MVC versus 25%
MVC), and are thus excluded from this comparison.

In future studies, it may be

interesting to investigate both young and older subject populations using the same
exercise protocol to determine group differences. Larger subject populations may be able
to more clearly define whether aging itself has an effect on muscle hemodynamics and
metabolism.
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Table 4. Comparison between Young and Older Healthy Subjects

Baseline Parameters

Young HC
(n = 9)

Older HC
(n = 13)

BF (ml/100 ml/min)

1.76 ± 0.4

2.27 ± 0.52

0.448

0.12 ± 0.02

0.16 ± 0.05

0.518

StO2 (%)

68.0 ± 1.0

69.1 ± 1.0

0.464

MVC (N·m)

27.3 ± 0.6

24.14 ± 0.84

0.189

2

(ml O2/100 g/min)

p-value
’ -test)

6.4 Study Limitations
Influence of Myoglobin on Oxygenation Measurements
In optical measurements of muscle tissue, there is some expected contamination of the
signal due to the presence of cellular myoglobins, which have very similar optical spectra
as hemoglobins [33]. Because of this overlap, the presence of both chromophores cannot
be readily separated by NIR optical measurements. Many authors have argued the
importance of this contamination, and most agree that NIR signals originate primarily (>
90%) from hemoglobins [33, 112, 113].
The technique developed in this study focuses on muscle oxygen consumption under
moderate working conditions. Myoglobins have a much higher affinity for oxygen than
hemoglobins [114], and for the mild physiological manipulations presented in this work,
it is expected that myoglobins would remain mostly oxygenated. Therefore, dynamic
oxygenation changes presented in these results may be viewed as a combined hemoglobin
and myoglobin deoxygenation, with a minimal contribution from myoglobins.
Furthermore, it is reasonable to expect that flow measurements (DCS) are not affected by
myoglobin contamination, as myoglobins reside statically in the muscle tissues.
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Detectable flow changes, by contrast, are determined from the moving red blood cells
within the vasculature.

Influence of Adipose Tissue Thickness and Skin Blood Flow
One challenge facing NIR optical measurements is the influence of adipose tissue
thickness (ATT), particularly in subjects with a higher BMI than average.

The

penetration depth of near-infrared light in biological tissue is roughly half that of the
source-detector separation [28]. Although fat has low absorption in the NIR range [1], if
the ATT layer is sufficiently thick, a larger portion of the detected signal could
potentially originate from the skin and fat, and may therefore distort the true
hemodynamic measurement of muscle. The measurements acquired in this study utilized
a source-detector separation of 2.0 cm, which correlates to a probing depth of ~1 cm.
The average ATT for the young healthy subject population was 1.5 ± 0.2 mm, and 3.1 ±
0.4 and 2.9 ± 0.4 for the FM and HC populations, respectively. This ATT is considerably
less than this penetration depth, suggesting that the NIR light adequately probes muscle
tissue. Previous work has shown that for a source-detector separation of 2 cm or greater,
the contribution of the skin is < 5% of total light absorption, and the detected signal is
mainly from muscle tissue [115]. Some researchers in the field have attempted to correct
for light absorption in superficial tissues by using a two-layer model [33, 116]. Others
have developed algorithms derived from Monte Carlo simulations with in vivo
measurements [117] aimed at correcting for variation in measurement sensitivity due to
ATT. These algorithms may be useful to employ in future work, especially where the
subject population has highly varied ATT, or when investigating deeper muscle tissue.
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T
thi

w
~3

’

[115] imply, however, that up to the ATT observed in
S/D S

10
w

TT

2

or BF was observed for any

population. It is therefore reasonable to assume that skin and ATT did not adversely
influence the measurements.

Influence of γ Assumption
2

(see Section 2.4), the percentage of blood contained

γ w

w

change in blood volume during exercise, which manifests as an increase in [tHb] (average
~20% in the young healthy population).

Because absorption is high in larger vessels,

NIRS/DCS signals originate primarily from the arterioles, capillaries, and venules of the
microvasculature [26]. It may be therefore assumed that the detected blood volume
increase is due to changes in these small vessels.
Part of the observed volume increase is likely due to capillary recruitment, a normal
physiological event which increases the area for metabolic exchange within muscle in
response to increased demand from exercise [118]. Previous work in mathematical
modeling of NIRS measurements [119] suggests that changes in blood volume during
exercise are primarily due to the changes in number of microvascular units perfused, and
attributes the volume increase to capillaries. In this case, capillary volume increase is
w

γ

Part of the volume increase may also be due to changes in the venous compartment
during exercise. Venules are considerably more compliant than arterioles, which makes
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them more capable of accommodating volume changes. To evaluate the maximum
γ

w

volume (Δ[tHb]) is due solely to changes in the venous compartment (Vv), while the
volume in the arterial compartment remains constant (Va). In this case an average ~20%
Δ[tHb] (now indicative of ΔVv w
Section 2.4
in r

γrest ≈ 67
~7

2

v/(Vv+Va),

see

[ γrest/γexercise – 1) × 100]. Considering the fact that r

2

[13]

γ
γexercise ≈ 73

w
T

γ =

γ

increases several fold during exercise (see Figure 17), the minor variation introduced by
γ
γw
D Sw

2

measurement, as BF is measured directly by the

γ

6.5 Advantages and Disadvantages of NIRS/DCS
The NIRS/DCS protocol developed in this study holds great promise for investigation
of local hemodynamics and metabolism in muscle during exercise. However, one should
consider the disadvantages as well as the benefits compared to alternative measurement
techniques.
The primary advantage of NIRS/DCS technology is that it is entirely noninvasive,
making the technique ideal for research purposes, especially with fragile patient
populations, or pediatrics. Compared to catheterization or blood sampling [29] for

2

measurement, NIRS/DCS requires much less setup and training, and is significantly more
comfortable for the subject. The instrumentation of NIRS/DCS technology is also quite
portable, which makes it an ideal diagnostic tool for subjects with limited mobility.
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The running cost of a NIRS/DCS hybrid instrument is very inexpensive compared to
other techniques which evaluate local perfusion and oxygen consumption [15]. PET,
perfusion MRI, and

31

P-MRS all require significant initial investment, and consecutive

measurements are expensive and require well-trained technicians. NIRS/DCS can easily
be used for repeated measurements at very minimal cost. This is particularly beneficial
in a research environment, where trial and error is an integral and unavoidable part of
many studies.
This protocol also has the advantage of allowing continuous measurement during
exercise. Many previous efforts using optical technology to evaluate hemodynamic and
metabolic response to exercise have focused on monitoring values before and following
exercise, due to the scattering effects of muscle motion [50], or the temporal limitations
of measuring BF or

2

via occlusion. It has been shown, however, that these dynamic

parameters rapidly return to baseline following the end of exercise, or even exhibit
hyperemic response in the case of heavy exercise [68]. Without continuous monitoring
during and immediately following exercise, physiologically useful information may be
lost between measurements.
NIRS/DCS is limited to measuring local perfusion under the probe site in the
microvasculature. In some cases, measuring local flow can be preferable to monitoring
limb flow, as muscle groups in the limbs can exhibit a great deal of heterogeneity in
hemodynamic/metabolic response with aging or disease [17]. However, if a specific
application requires quantification of regional or limb flow, measurement must be
performed by monitoring the larger vessels. In this case, Doppler ultrasound is a popular
method for measuring flow through major arteries.
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While this method is also

noninvasive and portable, it requires precise probe placement in relation to the vessel,
which can become easily dislodged during exercise.

To acquire muscle

2

measurement in conjunction with Doppler ultrasound by the Fick method, additional
blood sampling is required.

These regional measurements are also not necessarily

reflective of actual delivery and utilization of oxygen in local skeletal muscle [31].
Another restriction to the application of NIRS/DCS technology during exercise is that
measurement is limited to only the relaxation phase of rhythmic exercise. By contrast,
ultrasound Doppler can monitor flow throughout the entire contraction/relaxation cycle
[15]. Flow is much higher in major arteries during relaxation compared to contraction
[120], and it has been shown that arterial inflow occurs almost exclusively between
contractions [121].

During contraction, microvascular perfusion is inhibited in part

because of increased intramuscular pressure and extravascular compression [50].
Because NIRS/DCS monitors only the microvasculature, it is reasonable to confine BF
and

2

to the relaxation phase when using this measurement technique.

6.6 Future Improvements for Gating Algorithm
The gating algorithm developed for this study relies on the availability of a control
signal from a dynamometer. In some cases, a dynamometer may not be readily available,
or accessible, particularly for patients with limited mobility. In addition, the position of
the dynamometer lever is a secondary measurement of muscle contraction. A more direct
measure of muscle contraction status, such as EMG, would allow for more precise timing
of data acquisition. Additionally, automatic initiation of the algorithm would be an
effective solution to reduce the noise seen at the onset of exercise (see Figures 13, 14, and
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15). Ideally, in future development of this protocol, EMG will be incorporated into the
instrumentation as an alternative method to dynamometer-based signal control, and the
gating algorithm will be fully automated.

6.7 Conclusions
This study demonstrates the novel application of NIRS and DCS technologies to
continuously monitor absolute local muscle hemodynamic and metabolic parameters
during exercise in a young healthy population, an older FM subject population, and an
older age-matched healthy population. Previous problems with motion artifact during
exercise were addressed with the use of an embedded software gating algorithm which
monitored the muscle contraction status to determine appropriate times for data
acquisition.
The results of the validation study in a young healthy population were consistent with
previous literature findings, and the results of the fibromyalgia study sh w
2,

and StO2 at the end of moderate exercise.

Although the results of this study are encouraging, further experimentation is required to
fully validate the technique.

The protocol has only been used with mild intensity

exercise, and validation is of a qualitative nature (literature comparison).

To fully

establish the reliability of the technique, a range of exercise intensities and durations
should be investigated, with concurrent measurement by another established modality
(e.g. ASL-MRI, 31P-MRS). Concurrent measurement would allow for quantitative multipoint comparison with thorough statistical analysis. A larger subject population would be
desirable to reduce the perceived error due to normal physiological variation.
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The results from the FM study indicate that the technology and protocol are suitable
for monitoring hemodynamic and metabolic parameters in an older disease population,
and can distinctly identify group differences.

While the results of the study are

inconclusive related to the pathophysiology underlying FM, due to the confounding
variable of MVC, the study shows that the technique may be highly applicable to future
investigations involving exercise response of patients diagnosed with FM. To further
verify differences between the disease population and their healthy counterpart, a more
carefully selected contingent of subjects with similar physical characteristics should be
assessed. Larger groups may also help verify the validity of the observed differences,
and reduce natural inter-subject variation.
Because muscle function is closely linked to oxidative metabolism and flow
regulation, this technique is highly relevant for investigation of muscle physiology and
pathology.

The technique finds broad application to medical research, exercise

physiology, sports medicine, disease diagnosis, and treatment evaluation.

As

spectroscopic technologies improve, this technique will become more accessible, with
higher quality real-time data. The advantages suggest that NIRS/DCS would be an
attractive alternative for more expensive or invasive methods of BF, StO2
quantification.
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CHAPTER 7: SUMMARY AND PERSPECTIVES
In summary of this research study, I have presented a novel method for quantifying
absolute muscle BF, tissue blood

2

simultaneously during rhythmic

exercise, and demonstrated the potential application of the technique to investigating
pathophysiology of disease which affects skeletal muscle. The method relies on a hybrid
NIRS/DCS instrument for measurement, which was developed and built in our lab.
Several facets of the design and completion of this study included my own contributions.
These include design, construction, and integration of DCS photodetector power supply
electronics (Chapter 2.3), design of the relative signal calibration protocol (Chapter 3.3),
design of the exercise protocol (Chapter 3.4), co-development of the gating algorithm
(Chapter 3.5), subject recruitment and acquisition of data in both a young healthy
population, as well as FM subjects with age-matched HC subjects (Chapters 4 and 5), and
general methods of data analysis (Chapters 4 and 5). The results of the validation study
in young healthy subjects have also been peer-reviewed and published [122].
T

’
2),

the oxygen supply (BF), and the oxygen balance (StO2)

should all be evaluated simultaneously. Furthermore, it is critical to monitor the dynamic
profiles of these variables in response
q

2.

S

D S

The hybrid instrument developed in our lab combines the two

spectroscopies in one streamlined measurement, providing a wealth of information that
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gives a more complete picture of the local oxygenation kinetics within skeletal muscle
than traditional methods.
This study has effectively addressed previous problems associated with DCS-based
measurements, including quantification of relative signals and removal of motion artifact
from skeletal muscle contraction. While the occlusion techniques used in the protocol to
determine absolute baseline

2

are not new, the application to calibration of the

direct but relative measurement during exercise has never been investigated, to the
’

w
2,

absolute quantification of all presented

and StO2) has never been achieved during exercise.

Another novel component of this study is the application of a dynamometer-based
software gating algorithm to reduce motion artifact. The current algorithm is highly
effective, but future development may further improve signal characteristics. Alternative
sources for input signal, as well as more automated initiation and termination need to be
investigated.
This study also demonstrates the first efforts to apply noninvasive optical technology
to monitoring hemodynamics and metabolism continuously during exercise in
fibromyalgia. While the results are somewhat inconclusive, the study shows the potential
for using such technology to investigate responses to such stimulus in a fragile patient
population, and could serve as a starting point for many other investigational studies on
vasoregulation and metabolism in fibromyalgia.

Data analysis for this study was

achieved using custom MATLAB scripts, which read files generated by the hybri
23

2,

variables (e.g. StO2, [HbO2], [Hb], [tHb]) (see Chapter 4).
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and oxygenation

The applications of this technique are many and varied. Normal muscle and exercise
physiology, disease pathophysiology, diagnosis, treatment evaluation, sports medicine
and rehabilitation all benefit from the ability to continuously monitor local hemodynamic
and metabolic regulation. The method and instrument are especially suited to a research
and clinical environment, due to the noninvasive, inexpensive, and portable nature of the
technology. The findings of this study further push the limits of optical measurement in
medicine.
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APPENDIX A: GLOSSARY
SYMBOLS
α

Ratio of Dynamic to Static Scatterers (0-1)

ac

Modulated Light Amplitude

C

Hemoglobin Concentration of Whole Blood

γ

Percentage of Blood Volume Contained in the Venous Compartment

D

Photon Diffusion Constant

DB

Effective Diffusion Coefficient

dc

Average Light Intensity

g1

Normalized Electric Field Temporal Autocorrelation Function

G1

Unnormalized Electric Field Temporal Autocorrelation Function

g2

Normalized Intensity Temporal Autocorrelation Function

I

Intensity

k0

Wavevector of Photons in Medium (k0 = 2π /λ

λ

Wavelength

n

Ratio of Sample and Air Index of Refraction

φ

Phase Modulation of NIR Light

r

Source-detector Separation

r

Position Vector

ρ

Source-detector Separation

<Δ

2

τ>

Mean- q

D

Sac

Slope of r vs. ln(ac·r2) Curve

Sdc

Slope of r vs. ln(dc·r2) Curve

S
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τ

Sφ

S

φ

S0

Source-light Distribution

τ

Correlation Function Decay Time

µa

Absorption Coefficient

µs ’

Reduced Scattering Coefficient

[x]

Concentration of x

v

Speed of Light in Medium

Va

Blood Volume in the Arterial Compartment

Vv

Blood Volume in the Venous Compartment

ω

Angular Frequency of Modulation

TERMS
APD

Avalanche Photodiode

ASL-MRI Arterial Spin-Labeled Magnetic Resonance Imaging (Perfusion MRI)
ATT

Adipose Tissue Thickness

BF

Blood Flow

BFI

w

αDB)

CW

Continuous Wave

DCS

Diffuse Correlation Spectroscopy

DLS

Dynamic Light Scattering

DWS

Diffusing Wave Spectroscopy

FD

Frequency Domain

FM

Fibromyalgia
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Hb

Deoxy-hemoglobin

HbO2

Oxy-hemoglobin

HC

Healthy Control

MVC

Maximal Voluntary Contraction

NIR

Near-Infrared

NIRS

Near-Infrared Spectroscopy

[O]a

Arterial Oxygen Concentration

[O]v

Venous Oxygen Concentration

OEF

Oxygen Extraction Fraction

31

31-phosphorus Magnetic Resonance Spectroscopy

P-MRS

PET

Positron Emission Tomography

PMT

Photomultiplier Tube

RBC

Red Blood Cell

SNR

Signal to Noise Ratio

SaO2

Arterial Blood Oxygen Saturation

StO2

Tissue Blood Oxygen Saturation

TD

Time Domain

tHb

Total Hemoglobin

2

Oxygen Consumption Rate
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